denintuzumab mafodotin

denintuzumab mafodotin · Seagen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for denintuzumab mafodotin, covering 2019-01-08 to 2019-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma [Phase 2]

See pricing